Arrowhead Research | ARWR - Stock


Arrowhead Research reported $-173.08M in Stock for its fiscal quarter ending in December of 2024.





Stock Change Date
Agios Pharmaceuticals USD 32.03M 1.19M Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Incyte USD 83.45M 24K Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Ligand Pharmaceuticals USD 11.9M 3.59M Sep/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025